Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: Observational study

BMJ (Online)

Volumn 344, Issue 7859, 2012, Pages

  Shiomi, Hiroki ^a   Nakagawa, Yoshihisa ^b   Morimoto, Takeshi ^c   Furukawa, Yutaka ^d   Nakano, Akira ^e   Shirai, Shinichi ^f   Taniguchi, Ryoji ^g   Yamaji, Kyohei ^f   Nagao, Kazuya ^h   Suyama, Tamaki ⁱ   Mitsuoka, Hirokazu ^j   Araki, Makoto ^k   Takashima, Hiroyuki ^l   Mizoguchi, Tetsu ^m   Eisawa, Hiroshi ⁿ   Sugiyama, Seigo ^o   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b TENRI HOSPITAL   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^e UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^f KOKURA MEMORIAL HOSPITAL   (Japan)

^g HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^h OSAKA RED CROSS HOSPITAL   (Japan)

ⁱ Sapporo Higashi Tokushukai Hospital   (Japan)

^j Kishiwada City Hospital   (Japan)

^k SHIMADA MUNICIPAL HOSPITAL   (Japan)

^l SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

^m MITSUBISHI KYOTO HOSPITAL   (Japan)

ⁿ NISHI KOBE MEDICAL CENTER   (Japan)

^o KUMAMOTO UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; AGED; AORTA BALLOON; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DEATH; DOOR TO BALLOON TIME; FEMALE; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ONSET TO BALLOON TIME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK REDUCTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOM; TIME; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; HEART FAILURE; HEART INFARCTION; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84861912147     PISSN: 17561833     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.e3257     Document Type: Article

References (19)

1. Gibson C, Pride Y, Frederick P, Pollackjr C, Canto J, Tiefenbrunn A, et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the national registry of myocardial infarction from 1990 to 2006. Am Heart J 2008;156:1035-44.
2. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, et al. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 2008;29:609-17.
3. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
4. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians. Circulation 2007;117:296-329.
5. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008;29:2909-45.
6. Cannon CP. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7. (Pubitemid 30414505)
7. McNamara R, Wang Y, Herrin J, Curtis J, Bradley E, Magid D, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006;47:2180-6. (Pubitemid 43810139)
8. De Luca G, Suryapranata H, Zijlstra F, van't Hof AWJ, Hoorntje JCA, Gosselink ATM, et al. Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 2003;42:991-7. (Pubitemid 37108581)
9. Brodie BR, Stuckey TD, Wall TC, Kissling G, Hansen CJ, Muncy DB, et al. Importance of time to reperfusion for 30-day and late survival and recovery of left ventricular function after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1998;32:1312-9. (Pubitemid 28522388)
10. Brodie B, Hansen C, Stuckey T, Richter S, Versteeg D, Gupta N, et al. Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 2006;47:289-95. (Pubitemid 43063244)
11. Brodie BR, Gersh BJ, Stuckey T, Witzenbichler B, Guagliumi G, Peruga JZ, et al. When is door-to-balloon time critical?Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) tials. J Am Coll Cardiol 2010;56:407-13.
12. Hannan EL, Zhong Y, Jacobs AK, Holmes DR, Walford G, Venditti FJ, et al. Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol 2010;106:143-7.
13. Gersh BJ. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future? JAMA 2005;293:979-86. (Pubitemid 40271130)
14. Boden W, Eagle K, Granger C. Reperfusion strategies in acute ST-segment elevation myocardial infarction: a comprehensive review of contemporary management options. J Am Coll Cardiol 2007;50:917-29. (Pubitemid 47313604)
15. Gersh BJ, Anderson JL. Thrombolysis and myocardial salvage: results of clinical trials and the animal paradigm - paradoxic or predictable? Circulation 1993;88:296-306. (Pubitemid 23195459)
16. Krumholz H. A campaign to improve the timeliness of primary percutaneous coronary intervention door-to-balloon: an alliance for quality. JACC Cardiovasc Interv 2008;1:97-104. (Pubitemid 351459373)
17. Bradley EH, Nallamothu BK, Herrin J, Ting HH, Stern AF, Nembhard IM, et al. National efforts to improve door-to-balloon time results from the door-to-balloon alliance. J Am Coll Cardiol 2009;54:2423-9.
18. Flynn A, Moscucci M, Share D, Smith D, LaLonde T, Changezi H, et al. Trends in door-to-balloon time and mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Arch Intern Med 2010;170:1842-9.
19. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ 2006;332:1080. (Pubitemid 44365491)